SS
ATRS

Simplicity Solutions’s Antares Pharma, Inc. ATRS Stock Holding History

Simplicity Solutions’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,266
Closed -$49K – 998
2020
Q3 		$49K Hold
18,266
– – ﹤0.01% 851
2020
Q2 		$50K Sell
18,266
-4,520
-20% -$12.6K ﹤0.01% 862
2020
Q1 		$54K Sell
22,786
-28
-0.1% -$95 ﹤0.01% 708
2019
Q4 		$107K Sell
22,814
-2,869
-11% -$11.7K ﹤0.01% 814
2019
Q3 		$86K Buy
+25,683
New +$84.6K ﹤0.01% 700

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Simplicity Solutions's ATRS Position: Q4 2020 in Review

Simplicity Solutions sold out of Antares Pharma, Inc. (ATRS) in Q4 2020, closing a stake of 18,266 shares — an estimated $49K sold.

Simplicity Solutions first reported a position in ATRS in Q3 2019 and held it in 5 quarters. The position peaked at $107K in Q4 2019. 174 funds tracked by Wall St. Rank hold ATRS as of Q4 2020.

  • Simplicity Solutions reported no remaining Antares Pharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Simplicity Solutions sold 18,266 Antares Pharma, Inc. shares in Q4 2020, an estimated $49K.
  • Simplicity Solutions first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 5 quarters.
  • Simplicity Solutions's Antares Pharma, Inc. position peaked at $107K in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2020.

Based on Simplicity Solutions's 13F filing for Q4 2020, filed 9 Feb 2021.